Liposomal Bupivacaine Shows Limited Clinical Benefit After Third Molar Extraction - Top-Institutions - DentalSpire

Liposomal Bupivacaine Shows Limited Clinical Benefit After Third Molar Extraction

Extended-release anesthetic did not significantly improve postoperative pain, raising questions about its routine use in dental surgery.

  • By

  • Olivia Anderson

  • March 25, 2026

  • 3 min

Share

Top Institutions in Dental

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oral and Maxillofacial Surgery
    • Pain Management
    • Anesthesiology

  • #2

    University of California, San Francisco (UCSF) School of Dentistry
    University of California, San Francisco (UCSF) School of Dentistry

    San Francisco, CA

    Key Differentiators

    • Oral and Maxillofacial Surgery
    • Dental Anesthesiology
    • Pain Research

  • #3

    Harvard School of Dental Medicine
    Harvard School of Dental Medicine

    Boston, MA

    Key Differentiators

    • Oral and Maxillofacial Surgery
    • Pain Management
    • Clinical Pharmacology

  • #4

    University of North Carolina at Chapel Hill School of Dentistry
    University of North Carolina at Chapel Hill School of Dentistry

    Chapel Hill, NC

    Key Differentiators

    • Oral and Maxillofacial Surgery
    • Pain Management
    • Dental Pharmacology

Original Source(s)

Liposomal Bupivacaine Shows Limited Clinical Benefit After Third Molar Extraction

  • by Olivia Anderson

  • March 25, 2026

Related Content

Medical Oddities: Pig Semen, Meet Eye Drops

Evolution, sex, soil, and diets—this lineup covers a little bit of everything.

Reactive lymphoid hyperplasia of the appendix in children: a descriptive analysis of accompanying neural and stromal features

Toothbrush Contamination May Be Common, Awareness Low

A study links poor toothbrush hygiene habits to bacterial growth and limited patient knowledge.